{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "867.70",
    "chg": 2.55,
    "chgp": "0.29%",
    "dir": 1,
    "prev_price": "865.15",
    "mcapval": "4,362.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE191A01027",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "55.22 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Orchid Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-orchid-pharma-technically-bullish-or-bearish-3747693",
        "imagepath": "",
        "date": "2025-12-05 08:29:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 4 December 2025, Orchid Pharma’s technical trend has transitioned from mildly bearish to mildly bullish. This change indicates a tentative improvement in market sentiment, signalling that buyers may be gaining some control after a period of subdued momentum. However, this shift is mild, suggesting that the stock is not yet in a strong uptrend but is showing early signs of recovery.</p>\n<p><strong>Key Technical Indicators: Weekly vs Monthly Perspectives</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), a popular momentum indicator, reveals a divergence between weekly and monthly signals. The weekly MACD is mildly bullish, implying short-term momentum is improving. Conversely, the monthly MACD remains bearish, indicat..."
      },
      {
        "title": "Orchid Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharmas-technical-momentum-shifts-amid-mixed-market-signals-3747726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OrchidPharma_technicaldot_3747726.png",
        "date": "2025-12-05 08:06:50",
        "description": "Orchid Pharma has exhibited a notable shift in its technical momentum, reflecting a nuanced interplay of bullish and bearish signals across key indicators. Recent market data reveals a mild bullish trend on weekly charts contrasting with more cautious monthly signals, underscoring a complex technical landscape for this Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Orchid Pharma Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-forms-golden-cross-indicating-potential-bullish-breakout-3747044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OrchidPharma_goldencross_3747044.png",
        "date": "2025-12-04 18:00:31",
        "description": "Orchid Pharma, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential bullish breakout, suggesting a shift in long-term momentum and a possible trend reversal for the stock."
      },
      {
        "title": "Orchid Pharma’s Evaluation Metrics Revised Amid Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3735202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_mojoScore_3735202.png",
        "date": "2025-11-28 10:05:12",
        "description": "Orchid Pharma has experienced a revision in its evaluation metrics reflecting a more cautious market assessment. This shift follows a series of financial and operational challenges that have influenced the company’s standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Orchid Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-orchid-pharma-fallingrising-3732074",
        "imagepath": "",
        "date": "2025-11-27 00:29:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Outperformance</strong></p>\n<p>Orchid Pharma’s stock has demonstrated a strong upward trajectory over the past month, surging by 21.35%, significantly outperforming the Sensex’s modest 1.66% gain during the same period. This recent rally is further underscored by the stock’s outperformance relative to its sector, with a 2.64% higher return on the day. The stock has also recorded gains for two consecutive days, accumulating a 4.68% increase in that span. Intraday, the share price touched a high of ₹898.45, marking a 6.69% rise from previous levels, signalling robust buying interest.</p>\n<p>Technical indicators support this positive momentum, as Orchid Pharma is trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day ave..."
      },
      {
        "title": "Is Orchid Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-orchid-pharma-technically-bullish-or-bearish-3710247",
        "imagepath": "",
        "date": "2025-11-18 08:30:22",
        "description": "As of 17 November 2025, the technical trend for Orchid Pharma has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the monthly MACD showing a bearish signal. While the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the monthly indicators and the lack of strong signals from the RSI and OBV. The Bollinger Bands present a mixed picture with a bullish weekly stance but a mildly bearish monthly view. Overall, the bearish indicators outweigh the bullish ones, leading to the current mildly bearish assessment...."
      },
      {
        "title": "Orchid Pharma Shows Mixed Technical Signals Amid Market Volatility and Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharmas-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-mixed-performance-3710521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_technicaldot_3710521.png",
        "date": "2025-11-18 08:12:54",
        "description": "Orchid Pharma, a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently priced at 857.95. The stock has experienced a 52-week high of 1,998.00 and a low of 603.80. Its performance over five years shows a substantial return compared to the Sensex, indicating potential resilience."
      },
      {
        "title": "Orchid Pharma Hits Day High with 8.04% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-hits-day-high-with-804-intraday-surge-3707763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_priceRelatedfactors_3707763.png",
        "date": "2025-11-17 15:01:30",
        "description": "Orchid Pharma's stock has surged today, outperforming its sector and achieving consecutive gains over the past two days. Currently trading above key moving averages, the stock has shown a significant long-term increase despite recent declines. The broader market is also experiencing positive momentum, particularly among mid-cap stocks."
      },
      {
        "title": "How has been the historical performance of Orchid Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-orchid-pharma-3694457",
        "imagepath": "",
        "date": "2025-11-12 23:40:13",
        "description": "Answer:\nThe historical performance of Orchid Pharma shows a significant improvement in financial metrics over the years, particularly from March 2023 to March 2025.\n\nBreakdown:\nOrchid Pharma's net sales have steadily increased from 665.90 Cr in March 2023 to 921.93 Cr in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar trend, rising from 665.90 Cr to 921.93 Cr during the same period. The company's operating profit (PBDIT) also improved significantly, increasing from 103.05 Cr in March 2023 to 144.65 Cr in March 2025, although the operating profit margin slightly decreased from 12.56% to 12.71%. Profit before tax rose from 55.25 Cr to 95.56 Cr, and profit after tax increased from 55.25 Cr to 95.76 Cr, indicating a strong recovery from previous losses. The consolidated net profit showed a remarkable increase from 46.32 Cr in March 2023 to 99.66 Cr in March 2025...."
      }
    ],
    "total": 287,
    "sid": "653435",
    "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "details": "Orchid Pharma Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2019 to December 30, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on December 30, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - AGM/Book Closure",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>Orchid Pharma Limited has informed the Exchange regarding Board meeting held on August 12, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "12-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Orchid Pharma technically bullish or bearish?

2025-12-05 08:29:45

Recent Technical Trend Shift

As of 4 December 2025, Orchid Pharma’s technical trend has transitioned from mildly bearish to mildly bullish. This change indicates a tentative improvement in market sentiment, signalling that buyers may be gaining some control after a period of subdued momentum. However, this shift is mild, suggesting that the stock is not yet in a strong uptrend but is showing early signs of recovery.

Key Technical Indicators: Weekly vs Monthly Perspectives

Examining the Moving Average Convergence Divergence (MACD), a popular momentum indicator, reveals a divergence between weekly and monthly signals. The weekly MACD is mildly bullish, implying short-term momentum is improving. Conversely, the monthly MACD remains bearish, indicat...

Read More

Orchid Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-05 08:06:50

Orchid Pharma has exhibited a notable shift in its technical momentum, reflecting a nuanced interplay of bullish and bearish signals across key indicators. Recent market data reveals a mild bullish trend on weekly charts contrasting with more cautious monthly signals, underscoring a complex technical landscape for this Pharmaceuticals & Biotechnology stock.

Read More

Orchid Pharma Forms Golden Cross, Signalling Potential Bullish Breakout

2025-12-04 18:00:31

Orchid Pharma, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential bullish breakout, suggesting a shift in long-term momentum and a possible trend reversal for the stock.

Read More

Orchid Pharma’s Evaluation Metrics Revised Amid Challenging Financial and Market Conditions

2025-11-28 10:05:12

Orchid Pharma has experienced a revision in its evaluation metrics reflecting a more cautious market assessment. This shift follows a series of financial and operational challenges that have influenced the company’s standing within the Pharmaceuticals & Biotechnology sector.

Read More

Why is Orchid Pharma falling/rising?

2025-11-27 00:29:46

Recent Price Movement and Market Outperformance

Orchid Pharma’s stock has demonstrated a strong upward trajectory over the past month, surging by 21.35%, significantly outperforming the Sensex’s modest 1.66% gain during the same period. This recent rally is further underscored by the stock’s outperformance relative to its sector, with a 2.64% higher return on the day. The stock has also recorded gains for two consecutive days, accumulating a 4.68% increase in that span. Intraday, the share price touched a high of ₹898.45, marking a 6.69% rise from previous levels, signalling robust buying interest.

Technical indicators support this positive momentum, as Orchid Pharma is trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day ave...

Read More

Is Orchid Pharma technically bullish or bearish?

2025-11-18 08:30:22

As of 17 November 2025, the technical trend for Orchid Pharma has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the monthly MACD showing a bearish signal. While the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the monthly indicators and the lack of strong signals from the RSI and OBV. The Bollinger Bands present a mixed picture with a bullish weekly stance but a mildly bearish monthly view. Overall, the bearish indicators outweigh the bullish ones, leading to the current mildly bearish assessment....

Read More

Orchid Pharma Shows Mixed Technical Signals Amid Market Volatility and Resilience

2025-11-18 08:12:54

Orchid Pharma, a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently priced at 857.95. The stock has experienced a 52-week high of 1,998.00 and a low of 603.80. Its performance over five years shows a substantial return compared to the Sensex, indicating potential resilience.

Read More

Orchid Pharma Hits Day High with 8.04% Intraday Surge

2025-11-17 15:01:30

Orchid Pharma's stock has surged today, outperforming its sector and achieving consecutive gains over the past two days. Currently trading above key moving averages, the stock has shown a significant long-term increase despite recent declines. The broader market is also experiencing positive momentum, particularly among mid-cap stocks.

Read More

How has been the historical performance of Orchid Pharma?

2025-11-12 23:40:13

Answer: The historical performance of Orchid Pharma shows a significant improvement in financial metrics over the years, particularly from March 2023 to March 2025. Breakdown: Orchid Pharma's net sales have steadily increased from 665.90 Cr in March 2023 to 921.93 Cr in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar trend, rising from 665.90 Cr to 921.93 Cr during the same period. The company's operating profit (PBDIT) also improved significantly, increasing from 103.05 Cr in March 2023 to 144.65 Cr in March 2025, although the operating profit margin slightly decreased from 12.56% to 12.71%. Profit before tax rose from 55.25 Cr to 95.56 Cr, and profit after tax increased from 55.25 Cr to 95.76 Cr, indicating a strong recovery from previous losses. The consolidated net profit showed a remarkable increase from 46.32 Cr in March 2023 to 99.66 Cr in March 2025....

Read More

View All News